Rhythm Pharmaceuticals, Inc.RYTMNASDAQ
LOADING
|||
Cash Flow Under Pressure
Trending higher, below historical average, strong compound growth.
Left:
||||
Operating cash flow minus capital expenditures
Latest
$-113.88M
↓ 20% below average
Average (9y)
$-95.12M
Historical baseline
Range
High:$-6.99M
Low:$-177.71M
CAGR
+36.3%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-113.88M | +16.4% |
| 2023 | $-136.20M | +23.4% |
| 2022 | $-177.71M | -17.3% |
| 2021 | $-151.44M | -23.9% |
| 2020 | $-122.19M | +3.1% |
| 2019 | $-126.14M | -100.9% |
| 2018 | $-62.78M | -112.1% |
| 2017 | $-29.59M | -21.9% |
| 2016 | $-24.28M | -247.1% |
| 2015 | $-6.99M | - |